Class-3 semaphorins: Potent multifunctional modulators for angiogenesis-associated diseases

Area of Science:

• Molecular Biology
• Cell Biology
• Pathophysiology

Background:

• Semaphorins influence diverse pathophysiological processes, including immune responses and angiogenesis.
• Class-3 Semaphorins (SEMA3) are key regulators of angiogenesis, a process implicated in numerous diseases.
• Current therapeutic strategies targeting angiogenesis show limited efficacy due to complex underlying mechanisms.

Purpose of the Study:

• To elucidate the specific mechanisms of SEMA3 in angiogenesis across various diseases.
• To address the conflicting roles of SEMA3 in pathological angiogenesis.
• To evaluate SEMA3 as a potential therapeutic target for angiogenesis-associated diseases.

Main Methods:

• Literature review of existing studies on semaphorins and angiogenesis.
• Analysis of diverse disease models involving angiogenesis.
• Synthesis of evidence regarding SEMA3's dual role in promoting or inhibiting angiogenesis.

Main Results:

• SEMA3 plays a critical role in regulating angiogenesis in various pathological conditions.
• Evidence suggests SEMA3 can both inhibit and promote pathological angiogenesis, depending on the disease context.
• The precise mechanisms of SEMA3 in diverse angiogenesis-associated diseases require further elucidation.

Conclusions:

• SEMA3 exhibits a complex and context-dependent role in angiogenesis.
• Understanding SEMA3's multifaceted functions is crucial for developing effective anti-angiogenic therapies.
• SEMA3 represents a promising therapeutic target for managing angiogenesis-related diseases.